BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

914 related articles for article (PubMed ID: 16097798)

  • 1. Ochratoxin a causes DNA damage and cytogenetic effects but no DNA adducts in rats.
    Mally A; Pepe G; Ravoori S; Fiore M; Gupta RC; Dekant W; Mosesso P
    Chem Res Toxicol; 2005 Aug; 18(8):1253-61. PubMed ID: 16097798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ochratoxin A: lack of formation of covalent DNA adducts.
    Mally A; Zepnik H; Wanek P; Eder E; Dingley K; Ihmels H; Völkel W; Dekant W
    Chem Res Toxicol; 2004 Feb; 17(2):234-42. PubMed ID: 14967011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cytogenetic results supporting a DNA nonreactive mechanism for ochratoxin A, potentially relevant for its carcinogenicity.
    Mosesso P; Cinelli S; Piñero J; Bellacima R; Pepe G
    Chem Res Toxicol; 2008 Jun; 21(6):1235-43. PubMed ID: 18500787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats.
    Kamp HG; Eisenbrand G; Janzowski C; Kiossev J; Latendresse JR; Schlatter J; Turesky RJ
    Mol Nutr Food Res; 2005 Dec; 49(12):1160-7. PubMed ID: 16302199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative DNA damage induced by Ochratoxin A in the HK-2 human kidney cell line: evidence of the relationship with cytotoxicity.
    Arbillaga L; Azqueta A; Ezpeleta O; López de Cerain A
    Mutagenesis; 2007 Jan; 22(1):35-42. PubMed ID: 17130176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells.
    Kamp HG; Eisenbrand G; Schlatter J; Würth K; Janzowski C
    Toxicology; 2005 Jan; 206(3):413-25. PubMed ID: 15588931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotransformation and nephrotoxicity of ochratoxin B in rats.
    Mally A; Keim-Heusler H; Amberg A; Kurz M; Zepnik H; Mantle P; Völkel W; Hard GC; Dekant W
    Toxicol Appl Pharmacol; 2005 Aug; 206(1):43-53. PubMed ID: 15963343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA adduct formation in mice treated with ochratoxin A.
    Pfohl-Leszkowicz A; Chakor K; Creppy EE; Dirheimer G
    IARC Sci Publ; 1991; (115):245-53. PubMed ID: 1820338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats.
    Mally A; Völkel W; Amberg A; Kurz M; Wanek P; Eder E; Hard G; Dekant W
    Chem Res Toxicol; 2005 Aug; 18(8):1242-52. PubMed ID: 16097797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig.
    Faucet V; Pfohl-Leszkowicz A; Dai J; Castegnaro M; Manderville RA
    Chem Res Toxicol; 2004 Sep; 17(9):1289-96. PubMed ID: 15377164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression changes induced by ochratoxin A in renal and hepatic tissues of male F344 rat after oral repeated administration.
    Arbillaga L; Vettorazzi A; Gil AG; van Delft JH; García-Jalón JA; López de Cerain A
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):197-207. PubMed ID: 18417182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ochratoxin A: 13-week oral toxicity and cell proliferation in male F344/n rats.
    Rached E; Hard GC; Blumbach K; Weber K; Draheim R; Lutz WK; Ozden S; Steger U; Dekant W; Mally A
    Toxicol Sci; 2007 Jun; 97(2):288-98. PubMed ID: 17344223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA adduct formation by ochratoxin A: review of the available evidence.
    Mally A; Dekant W
    Food Addit Contam; 2005; 22 Suppl 1():65-74. PubMed ID: 16332624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans.
    Pfohl-Leszkowicz A; Manderville RA
    Mol Nutr Food Res; 2007 Jan; 51(1):61-99. PubMed ID: 17195275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of covalent adducts between DNA and ochratoxin a: a new factor in debate about genotoxicity and human risk assessment.
    Mantle PG; Faucet-Marquis V; Manderville RA; Squillaci B; Pfohl-Leszkowicz A
    Chem Res Toxicol; 2010 Jan; 23(1):89-98. PubMed ID: 19928877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of a new dechlorinated ochratoxin A derivative formed in opossum kidney cell cultures after pretreatment by modulators of glutathione pathways: correlation with DNA-adduct formation.
    Faucet-Marquis V; Pont F; Størmer FC; Rizk T; Castegnaro M; Pfohl-Leszkowicz A
    Mol Nutr Food Res; 2006 May; 50(6):530-42. PubMed ID: 16671059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA adduct formation and T lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene.
    Beland FA
    Res Rep Health Eff Inst; 1995 Oct; (72):1-27; discussion 29-39. PubMed ID: 11381742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage and micronuclei induced in rat and human kidney cells by six chemicals carcinogenic to the rat kidney.
    Robbiano L; Baroni D; Carrozzino R; Mereto E; Brambilla G
    Toxicology; 2004 Nov; 204(2-3):187-95. PubMed ID: 15388244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex- and strain-specific expression of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats.
    Pfohl-Leszkowicz A; Pinelli E; Bartsch H; Mohr U; Castegnaro M
    Mol Carcinog; 1998 Oct; 23(2):76-85. PubMed ID: 9808161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structurally related mycotoxins ochratoxin A, ochratoxin B, and citrinin differ in their genotoxic activities and in their mode of action in human-derived liver (HepG2) cells: implications for risk assessment.
    Knasmüller S; Cavin C; Chakraborty A; Darroudi F; Majer BJ; Huber WW; Ehrlich VA
    Nutr Cancer; 2004; 50(2):190-7. PubMed ID: 15623466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.